Drugs / Alhydrogel(R)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01657929 Comparator | Sep 2012 → Jan 2014 | avian influenza | Access to Advanced Health Institute (AAHI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Alhydrogel(R) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01657929 ↗ |
| Route | Intramuscular | “20 µg H5-VLP + 1 mg Alhydrogel(R) given IM” NCT01657929 ↗ |